241 related articles for article (PubMed ID: 4970034)
1. [Clinical aspects on the therapy of cerebral sclerosis].
Hoffmeister K
Med Klin; 1967 Jun; 62(23):910-2. PubMed ID: 4970034
[No Abstract] [Full Text] [Related]
2. [Hydergine in the treatment of cerebral circulatory disorders, including arteriosclerosis (author's transl)].
Lozeron H
Schweiz Rundsch Med Prax; 1974 May; 63(21):660-5. PubMed ID: 4208744
[No Abstract] [Full Text] [Related]
3. [Wallerox increases cerebral circulation and heart capacity].
Heynen U
Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
[No Abstract] [Full Text] [Related]
4. [On the encephalotrophic action of hydergine. Clinical study].
Garagnani Sciarretta B; Rimondini S; Martelli A
Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
[No Abstract] [Full Text] [Related]
5. Hydergine for cerebral arteriosclerosis.
Med Lett Drugs Ther; 1974 Mar; 16(5):21-2. PubMed ID: 4204775
[No Abstract] [Full Text] [Related]
6. [Changes of the cerebral circulation time influenced by hydergine].
Herzfeld U; Wittgen M
Arztl Forsch; 1971 Jul; 25(7):224-30. PubMed ID: 4998670
[No Abstract] [Full Text] [Related]
7. [Sympatholytic vasodilator in cerebral circulation disorders].
Lipke PR
Hospital (Rio J); 1969 Dec; 76(6):2159-65. PubMed ID: 4984915
[No Abstract] [Full Text] [Related]
8. [The effect of redergam on the cerebral circulation of patients who have suffered insults].
Khadzhiev D
Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(1):33-7. PubMed ID: 4976423
[No Abstract] [Full Text] [Related]
9. [Clinical experiences with the vascular action of dihydroergocristine].
Tomasi AM; Baggioni GF; Pozzar C
Minerva Cardioangiol; 1975 Jan; 23(1):7-19. PubMed ID: 806854
[No Abstract] [Full Text] [Related]
10. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
Rao DB; Norris JR
Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
[No Abstract] [Full Text] [Related]
11. [Effect of raubasine and dihydroergocristine on arteriosclerotic and hypertensive cerebral diseases].
Klein K
Vasa; 1973; 2(4):409-14. PubMed ID: 4202492
[No Abstract] [Full Text] [Related]
12. [Control of cerebral blood circulation time during long-term Wallerox therapy. Measurements using external scintillation counters].
Herzfeld U; Erbe H
Med Welt; 1971 Nov; 48(71):1933-5. PubMed ID: 5002422
[No Abstract] [Full Text] [Related]
13. [Treatment of patients with cerebral and diffuse arteriosclerosis with hydergine].
Avena G
Hospital (Rio J); 1970 Sep; 78(3):901-28. PubMed ID: 4994595
[No Abstract] [Full Text] [Related]
14. [Determinants estimating cerebral functions after long term therapy with hydergin].
Herzfeld U; Christian W; Ronge J; Wittgen M
Arztl Forsch; 1972 Jun; 26(6):215-28. PubMed ID: 4626216
[No Abstract] [Full Text] [Related]
15. [On the behavior of cerebrovascular resistance under the influence of sympatholytics].
Klein K; Siedek H
Wien Med Wochenschr; 1966 Jan; 116(1):20-2. PubMed ID: 4962461
[No Abstract] [Full Text] [Related]
16. Hydergine effect on cerebral circulation in cerebrovascular disease.
McHenry LC; Jaffe ME; Kawamura J; Goldberg HI
J Neurol Sci; 1971 Aug; 13(4):475-81. PubMed ID: 4998934
[No Abstract] [Full Text] [Related]
17. [Therapy of cerebral insufficiency].
Grill P; Broicher H
Dtsch Med Wochenschr; 1969 Nov; 94(47):2429-35. PubMed ID: 4981669
[No Abstract] [Full Text] [Related]
18. [Clinical experiences with gerontotherapeutic agent Wallerox (GN 468)].
Voegt H; Haid E
Med Klin; 1970 Nov; 65(46):2031-5. PubMed ID: 5000077
[No Abstract] [Full Text] [Related]
19. [On the symptomatology and therapy of cerebral arteriosclerosis in general practice].
Michaelis U
Ther Ggw; 1966 Dec; 105(12):1593-600. PubMed ID: 4962890
[No Abstract] [Full Text] [Related]
20. [Therapeutic findings in 23 geriatric cases treated with hydergine (clinical note)].
Tessler D
Hospital (Rio J); 1970 Jul; 78(1):267-70. PubMed ID: 4991827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
